Circulatory disease mortality in the Massachusetts tuberculosis fluoroscopy cohort study

European Journal of Epidemiology

Volumn 31, Issue 3, 2016, Pages 287-309

  Little, Mark P ^a   Zablotska, Lydia B ^b   Brenner, Alina V ^a   Lipshultz, Steven E ^c  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Circulatory disease; Fluoroscopy; Hypertension; Ionizing radiation; Tuberculosis

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CEREBROVASCULAR DISEASE; CHILD; CIRCULATORY DISEASE; COHORT ANALYSIS; DEATH; DISEASE ASSOCIATION; FLUOROSCOPY; HUMAN; HYPERTENSION; IONIZING RADIATION; ISCHEMIC HEART DISEASE; LUNG DISEASE; LUNG LOBECTOMY; MAJOR CLINICAL STUDY; RADIATION DOSE; RADIATION EXPOSURE; RISK; SMOKING; THORAX SURGERY; THYROID DISEASE; TUBERCULOSIS; UNITED STATES; X RAY; AGED; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; DIAGNOSTIC IMAGING; FEMALE; FOLLOW UP; LUNG; MALE; MASSACHUSETTS; MIDDLE AGED; MORTALITY; MYOCARDIAL ISCHEMIA; PROCEDURES; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RADIATION RESPONSE; RISK FACTOR; THYROID GLAND; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; DOSE FRACTIONATION; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; FLUOROSCOPY; FOLLOW-UP STUDIES; HUMANS; LUNG; MALE; MASSACHUSETTS; MIDDLE AGED; MYOCARDIAL ISCHEMIA; RADIATION DOSAGE; RADIATION INJURIES; RADIATION, IONIZING; RISK FACTORS; THYROID GLAND; TUBERCULOSIS; YOUNG ADULT;

EID: 84938818981     PISSN: 03932990     EISSN: 15737284     Source Type: Journal    
DOI: 10.1007/s10654-015-0075-9     Document Type: Article

References (58)

1. United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR). UNSCEAR 2006 Report. Annex A. Epidemiological Studies of Radiation and Cancer. New York: United Nations; 2008. p. 13–322.
2. Committee to Assess Health Risks from Exposure to Low Levels of Ionizing Radiation NRC. Health Risks from Exposure to Low Levels of Ionizing Radiation: BEIR VII—Phase 2. Washington, DC: National Academy Press; 2006. p. 1-406.
3. Little MP, Kleinerman RA, Stovall M, Smith SA, Mabuchi K. Analysis of dose response for circulatory disease after radiotherapy for benign disease. Int J Radiat Oncol Biol Phys. 2012;84(5):1101–9. doi:10.1016/j.ijrobp.2012.01.053.
4. Darby SC, Ewertz M, McGale P, et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med. 2013;368(11):987–98. doi:10.1056/NEJMoa1209825.
5. Mulrooney DA, Yeazel MW, Kawashima T, et al. Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort. BMJ. 2009;339:b4606.
6. Tukenova M, Guibout C, Oberlin O, et al. Role of cancer treatment in long-term overall and cardiovascular mortality after childhood cancer. J Clin Oncol. 2010;28(8):1308–15. doi:10.1200/JCO.2008.20.2267.
7. Shimizu Y, Kodama K, Nishi N, et al. Radiation exposure and circulatory disease risk: Hiroshima and Nagasaki atomic bomb survivor data, 1950–2003. BMJ. 2010;340:b5349.
8. Little MP, Azizova TV, Bazyka D, et al. Systematic review and meta-analysis of circulatory disease from exposure to low-level ionizing radiation and estimates of potential population mortality risks. Environ Health Perspect. 2012;120(11):1503–11. doi:10.1289/ehp.1204982.
9. McMillan TJ, Bennett MR, Bridges BA, et al. Circulatory disease risk. Report of the independent Advisory Group on Ionising Radiation. Health Protection Agency, Holborn Gate, 330 High Holborn, London; 2010. p. 1–116.
10. Boice JD Jr, Preston D, Davis FG, Monson RR. Frequent chest X-ray fluoroscopy and breast cancer incidence among tuberculosis patients in Massachusetts. Radiat Res. 1991;125(2):214–22.
11. Howe GR. Lung cancer mortality between 1950 and 1987 after exposure to fractionated moderate-dose-rate ionizing radiation in the Canadian fluoroscopy cohort study and a comparison with lung cancer mortality in the atomic bomb survivors study. Radiat Res. 1995;142(3):295–304.
12. Howe GR, McLaughlin J. Breast cancer mortality between 1950 and 1987 after exposure to fractionated moderate-dose-rate ionizing radiation in the Canadian fluoroscopy cohort study and a comparison with breast cancer mortality in the atomic bomb survivors study. Radiat Res. 1996;145(6):694–707.
13. Little MP, Boice JD Jr. Comparison of breast cancer incidence in the Massachusetts tuberculosis fluoroscopy cohort and in the Japanese atomic bomb survivors. Radiat Res. 1999;151(2):218–24.
14. Davis FG, Boice JD Jr, Hrubec Z, Monson RR. Cancer mortality in a radiation-exposed cohort of Massachusetts tuberculosis patients. Cancer Res. 1989;49(21):6130–6.
15. Zablotska LB, Little MP, Cornett RJ. Potential increased risk of ischemic heart disease mortality with significant dose fractionation in the Canadian fluoroscopy cohort study. Am J Epidemiol. 2014;179(1):120–31. doi:10.1093/aje/kwt244.
16. Boice JD Jr. Follow-up methods to trace women treated for pulmonary tuberculosis, 1930–1954. Am J Epidemiol. 1978;107(2):127–39.
17. Boice JD Jr, Rosenstein M, Trout ED. Estimation of breast doses and breast cancer risk associated with repeated fluoroscopic chest examinations of women with tuberculosis. Radiat Res. 1978;73(2):373–90.
18. Boice JD, Monson RR, Rosenstein M. Cancer mortality in women after repeated fluoroscopic examinations of the chest. J Natl Cancer Inst 1981;66(5):863–7.
19. Ridker PM. Inflammation, infection, and cardiovascular risk: how good is the clinical evidence? Circulation. 1998;97(17):1671–4.
20. Gura T. Infections: a cause of artery-clogging plaques? Science 1998;281(5373):35–7.
21. McCullagh P, Nelder JA. Generalized linear models. 2nd edition. Monographs on statistics and applied probability 37. Boca Raton, FL: Chapman and Hall/CRC; 1989. p. 1–526.
22. Preston DL, Lubin JH, Pierce DA, McConney ME. Epicure release 2.10. Seattle: Hirosoft International; 1998.
23. Austin PC, Tu JV. Automated variable selection methods for logistic regression produced unstable models for predicting acute myocardial infarction mortality. J Clin Epidemiol. 2004;57(11):1138–46. doi:10.1016/j.jclinepi.2004.04.003.
24. Akaike H. Information theory and an extension of the maximum likelihood principle. In: Petrov BN, Czáki F, editors. 2nd International symposium on information theory. Budapest: Akadémiai Kiadó; 1973. p. 267–81.
25. Akaike H. Likelihood of a model and information criteria. J Econ. 1981;16(1):3–14.
26. R Project. R version 3.1.1 http://www.r-project.org/. 2014.
27. Hastie T, Tibshirani R. Generalized additive models for medical research. Stat Methods Med Res. 1995;4(3):187–96.
28. Little MP, Tawn EJ, Tzoulaki I, et al. A systematic review of epidemiological associations between low and moderate doses of ionizing radiation and late cardiovascular effects, and their possible mechanisms. Radiat Res. 2008;169(1):99–109. doi:10.1667/RR1070.1.
29. Schultz-Hector S, Trott KR. Radiation-induced cardiovascular diseases: is the epidemiologic evidence compatible with the radiobiologic data? Int J Radiat Oncol Biol Phys. 2007;67(1):10–8. doi:10.1016/j.ijrobp.2006.08.071.
30. −/− mice. Radiat Res. 2011;175(5):665–76. doi:10.1667/RR2176.1.
31. Adams MJ, Grant EJ, Kodama K, et al. Radiation dose associated with renal failure mortality: a potential pathway to partially explain increased cardiovascular disease mortality observed after whole-body irradiation. Radiat Res. 2012;177(2):220–8. doi:10.1667/RR2746.1.
32. Lenarczyk M, Lam V, Jensen E, et al. Cardiac injury after 10 Gy total body irradiation: indirect role of effects on abdominal organs. Radiat Res. 2013;180(3):247–58. doi:10.1667/RR3292.1.
33. Rosenstein M. Personal communication to Mark Little. 2014.
34. Kusunoki Y, Kyoizumi S, Hirai Y, et al. Flow cytometry measurements of subsets of T, B and NK cells in peripheral blood lymphocytes of atomic bomb survivors. Radiat Res. 1998;150(2):227–36.
35. Danesh J, Whincup P, Lewington S, et al. Chlamydia pneumoniae IgA titres and coronary heart disease. Prospective study and meta-analysis. Eur Heart J. 2002;23(5):371–5. doi:10.1053/euhj.2001.2801.
36. Whincup P, Danesh J, Walker M, et al. Prospective study of potentially virulent strains of Helicobacter pylori and coronary heart disease in middle-aged men. Circulation. 2000;101(14):1647–52.
37. Grayston JT, Kronmal RA, Jackson LA, et al. Azithromycin for the secondary prevention of coronary events. N Engl J Med. 2005;352(16):1637–45. doi:10.1056/NEJMoa043526.
38. Cannon CP, Braunwald E, McCabe CH, et al. Antibiotic treatment of Chlamydia pneumoniae after acute coronary syndrome. N Engl J Med. 2005;352(16):1646–54. doi:10.1056/NEJMoa043528.
39. Lowe D, Raj K. Premature aging induced by radiation exhibits pro-atherosclerotic effects mediated by epigenetic activation of CD44 expression. Aging Cell. 2014;13(5):900–10. doi:10.1111/acel.12253.
40. Little MP, Gola A, Tzoulaki I. A model of cardiovascular disease giving a plausible mechanism for the effect of fractionated low-dose ionizing radiation exposure. PLoS Comput Biol. 2009;5(10):e1000539. doi:10.1371/journal.pcbi.1000539.
41. Fuster V, Moreno PR, Fayad ZA, Corti R, Badimon JJ. Atherothrombosis and high-risk plaque: part I: evolving concepts. J Am Coll Cardiol. 2005;46(6):937–54. doi:10.1016/j.jacc.2005.03.074.
42. Virmani R, Burke AP, Farb A, Kolodgie FD. Pathology of the vulnerable plaque. J Am Coll Cardiol. 2006;47(8 Suppl):C13–8. doi:10.1016/j.jacc.2005.10.065.
43. Little MP, Tawn EJ, Tzoulaki I, et al. Review and meta-analysis of epidemiological associations between low/moderate doses of ionizing radiation and circulatory disease risks, and their possible mechanisms. Radiat Environ Biophys. 2010;49(2):139–53. doi:10.1007/s00411-009-0250-z.
44. Little MP, Zablotska LB, Lipshultz SE. Ischemic heart disease after breast cancer radiotherapy. N Eng J Med. 2013;368(26):2523–4. doi:10.1056/NEJMc1304601#SA1.
45. Burns DM. Epidemiology of smoking-induced cardiovascular disease. Prog Cardiovasc Dis. 2003;46(1):11–29. doi:10.1016/S0033-0620(03)00079-3.
46. Wilson PW, D’Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97(18):1837–47.
47. Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364(9438):937–52. doi:10.1016/S0140-6736(04)17018-9.
48. Yamada M, Wong FL, Fujiwara S, Akahoshi M, Suzuki G. Noncancer disease incidence in atomic bomb survivors, 1958–1998. Radiat Res. 2004;161(6):622–32. doi:10.1667/RR3183
49. Azizova TV, Muirhead CR, Druzhinina MB, et al. Cardiovascular diseases in the cohort of workers first employed at Mayak PA in 1948–1958. Radiat Res. 2010;174(2):155–68. doi:10.1667/RR1789.1.
50. Azizova TV, Haylock RGE, Moseeva MB, Bannikova MV, Grigoryeva ES. Cerebrovascular diseases incidence and mortality in an extended Mayak Worker Cohort 1948–1982. Radiat Res. 2014;182(5):529–44. doi:10.1667/RR13680.1.
51. International Commission on Radiological Protection. ICRP statement on tissue reactions and early and late effects of radiation in normal tissues and organs - threshold doses for tissue reactions in a radiation protection context. ICRP publication 118. Ann. ICRP. 2012;41(1–2):1–322. doi:10.1016/j.icrp.2007.10.003.
52. Schöllnberger H, Kaiser JC, Jacob P, Walsh L. Dose-responses from multi-model inference for the non-cancer disease mortality of atomic bomb survivors. Radiat Environ Biophys. 2012;51(2):165–78. doi:10.1007/s00411-012-0410-4.
53. Little MP, Azizova TV, Bazyka D, et al. Comment on “Dose-responses from multi-model inference for the non-cancer disease mortality of atomic bomb survivors” (Radiat. Environ. Biophys (2012) 51:165–178) by Schöllnberger et al. Radiat Environ Biophys 2013;52(1):157–9. doi:10.1007/s00411-012-0453-6.
54. McGeoghegan D, Binks K, Gillies M, Jones S, Whaley S. The non-cancer mortality experience of male workers at British Nuclear Fuels plc, 1946-2005. Int J Epidemiol. 2008;37(3):506–18. doi:10.1093/ije/dyn018.
55. Muirhead CR, O’Hagan JA, Haylock RGE, et al. Mortality and cancer incidence following occupational radiation exposure: third analysis of the National Registry for Radiation Workers. Br J Cancer. 2009;100(1):206–12. doi:10.1038/sj.bjc.6604825.
56. Vrijheid M, Cardis E, Ashmore P, et al. Mortality from diseases other than cancer following low doses of ionizing radiation: results from the 15-Country Study of nuclear industry workers. Int J Epidemiol. 2007;36(5):1126–35. doi:10.1093/ije/dym138.
57. Krestinina LY, Epifanova S, Silkin S, et al. Chronic low-dose exposure in the Techa River Cohort: risk of mortality from circulatory diseases. Radiat Environ Biophys. 2013;52(1):47–57. doi:10.1007/s00411-012-0438-5.
58. Grosche B, Lackland DT, Land CE, et al. Mortality from cardiovascular diseases in the Semipalatinsk historical cohort, 1960–1999, and its relationship to radiation exposure. Radiat Res. 2011;176(5):660–9. doi:10.1667/RR2211.1.